857531-36-3

Upstream product

• 32017-76-8 (+/-)-2-(4-bromophenyl)oxirane 
• 40587-07-3 1-(4-bromophenyl)-2-(methylamino)ethanol 

Downstream Products

• 885595-75-5 tert-butyl 2-(4-bromophenyl)-2-(4-chlorophenyl)ethyl(methyl)carbamate 
• 942057-59-2 tert-butyl 2-(4-chlorophenyl)-2-(4-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)phenyl)ethyl(methyl)carbamate 
• 885595-50-6 (2-(4-bromophenyl)-2-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)-phenyl]-ethyl)-methyl-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

PHARMACEUTICAL COMBINATIONS COMPRISING PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS

The invention provides a combination comprising an ancillary compound (e.g. one, two or more ancillary compounds) and a compound of the formula (I) having protein kinase B inhibiting activity: wherein A is a saturated hydrocarbon linker group containing f

PHARMACEUTICAL COMPOUNDS

The invention provides compounds of the formula (I) having ROCK kinase and/or protein kinase p70S6K inhibiting activity: wherein A is a saturated hydrocarbon linker group containing from 1 to 7 carbon atoms, the linker group having a maximum chain length